NIH U2C ES030158 (PI Fiehn, O)

     The West Coast Metabolomics Center for Compound Identification

Use computational and experimental approaches for compound identifications

Agilent   (PI Fiehn, O. - UC Davis)

Metabolomic libraries and methods by mass spectrometry

Improve metabolite identification by standardized QTOF and GC-quad MS analyses of reference compounds.

01/01/07 to 10/30/2021

NSF MCB 1611846 (PI Hanson U Florida,  Fiehn, O. UC Davis; coPI et al)

Metabolite damage - a stumbling block for synthetic biology

To perform cheminformatic and metabolomic analyses to pinpoint chemical and biochemical damage to metabolites when used in synthetic biological applications.

09/15/16 to 08/31/2021

NIH U19 AG023122 (PI Cummings, S - Cal Pacific Medical Center Research Inst.

Longevity Consortium

To use metabolomics phenotyping to discern the causes of longevity in cross-sectional human cohorts and in cells and mouse experiments.

NIH U54DA049113 (PI Olivier, M. Wake Forest, Winston-Salem, NC; co-I Fiehn, O

Integrated Omics Analysis of Pain: Omics Data Generation Center

To generate blood metabolomics data at 0, 3, 6 months after a surgical procedure or musculoskeletal trauma to predict the transition from acute to chronic pain.

09/01/19 to 10/30/2024

DoD W818XWH - 18-2-0771 (PI Meyers, F. UC Davis, co-I Fiehn, O)

The UCD-DGMC TBI Precision Medicine Network for Complex Trauma

To use metabolomics on animal models and human subjects for predictive marker
identification.

 06/01/18 to 08/31/2023

NIH R01 AT010216 (PI McCann, S - Roswell Cancer Ctr)

Flaxseed effects on gut microbial metabolism and circulating inflammation-related metabolic profiles in African American and non-Hispanic white women

NIH U54 AI138370 (PI Lipkin, I - Columbia U)

Center for Solutions for ME/CFS (myalgic encephalomyelitis / chronic fatigue syndrome)

To use metabolomics on bulk cell populations using cell sub-type specific markers, and on analyses after orthostatic and exercise challenges of subjects